CH620207A5 - - Google Patents

Download PDF

Info

Publication number
CH620207A5
CH620207A5 CH1325075A CH1325075A CH620207A5 CH 620207 A5 CH620207 A5 CH 620207A5 CH 1325075 A CH1325075 A CH 1325075A CH 1325075 A CH1325075 A CH 1325075A CH 620207 A5 CH620207 A5 CH 620207A5
Authority
CH
Switzerland
Prior art keywords
liters
diethylcarbamoyl
embonic acid
methylpiperazine
embonate
Prior art date
Application number
CH1325075A
Other languages
German (de)
English (en)
Inventor
William Lee Torgeson
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CH620207A5 publication Critical patent/CH620207A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH1325075A 1973-06-27 1975-10-13 CH620207A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00374176A US3809294A (en) 1973-06-27 1973-06-27 Dispensing lung contacting powdered medicaments

Publications (1)

Publication Number Publication Date
CH620207A5 true CH620207A5 (xx) 1980-11-14

Family

ID=23475640

Family Applications (2)

Application Number Title Priority Date Filing Date
CH555174A CH577832A5 (xx) 1973-06-27 1974-04-23
CH1325075A CH620207A5 (xx) 1973-06-27 1975-10-13

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH555174A CH577832A5 (xx) 1973-06-27 1974-04-23

Country Status (24)

Country Link
US (1) US3809294A (xx)
JP (1) JPS6010737B2 (xx)
AR (1) AR198562A1 (xx)
AT (1) AT342211B (xx)
BE (1) BE813512A (xx)
CA (1) CA1043208A (xx)
CH (2) CH577832A5 (xx)
CS (1) CS182257B2 (xx)
DD (1) DD125188A5 (xx)
DE (1) DE2415360C2 (xx)
DK (1) DK152967C (xx)
ES (1) ES427755A1 (xx)
FR (1) FR2234905B1 (xx)
GB (1) GB1471917A (xx)
IE (1) IE40616B1 (xx)
IL (1) IL44401A (xx)
IT (1) IT1003994B (xx)
NL (1) NL178655C (xx)
PH (1) PH11643A (xx)
PL (1) PL89980B1 (xx)
SE (1) SE405448B (xx)
SU (1) SU537614A3 (xx)
YU (1) YU36435B (xx)
ZA (1) ZA741633B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998226A (en) * 1975-09-22 1976-12-21 Edward G. Gomez Inhalation device for encapsulated concentrates
US3994421A (en) * 1975-09-29 1976-11-30 American Cyanamid Company Unitary therapeutic aerosol dispenser
SE408265B (sv) * 1975-12-12 1979-06-05 Draco Ab Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
GR69682B (xx) * 1978-09-11 1982-07-08 Newhouse Michael T
DE3348370C2 (de) * 1982-10-08 2001-10-11 Glaxo Group Ltd Medikamenten-Packung und Verfahren zur Erzeugung eines zur Inhalation bestimmten Medikamenten-Pulver-Luftstroms
IT1217890B (it) * 1988-06-22 1990-03-30 Chiesi Farma Spa Dispositivo per l'inalazione di aerosol dosati
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5040527A (en) * 1990-12-18 1991-08-20 Healthscan Products Inc. Metered dose inhalation unit with slide means
US5186164A (en) * 1991-03-15 1993-02-16 Puthalath Raghuprasad Mist inhaler
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
EP0616525B1 (en) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmaceutical aerosol formulation
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
CA2125666C (en) * 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
ATE150296T1 (de) 1991-12-18 1997-04-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5839429A (en) * 1994-03-25 1998-11-24 Astra Aktiebolag Method and apparatus in connection with an inhaler
US5598836A (en) * 1995-05-26 1997-02-04 Healthscan Products, Inc. Metered dose inhalation unit with slide means
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
DE19740617A1 (de) * 1997-09-16 1999-03-18 Palas Gmbh Verfahren und Vorrichtung zum Erzeugen eines Feststoff-Aerosols
US6293279B1 (en) 1997-09-26 2001-09-25 Trudell Medical International Aerosol medication delivery apparatus and system
US6345617B1 (en) 1997-09-26 2002-02-12 1263152 Ontario Inc. Aerosol medication delivery apparatus and system
CA2406185C (en) 2000-04-11 2011-03-15 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
US7025058B2 (en) * 2001-04-26 2006-04-11 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US20030205226A1 (en) 2002-05-02 2003-11-06 Pre Holding, Inc. Aerosol medication inhalation system
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
EP1663159A4 (en) * 2003-09-10 2010-06-09 Map Pharmaceuticals Inc AEROSOL FORMULATIONS FOR THE DELIVERY OF DIHYDROERGOTAMINE TO THE SYSTEMIC CIRCULATION BY PULMONARY INHALATION
US8365725B2 (en) * 2004-09-13 2013-02-05 Oriel Therapeutics, Inc. Dry powder inhalers that inhibit agglomeration, related devices and methods
NL1027255C2 (nl) * 2004-10-15 2006-04-19 Lab Tickner Ag Inrichting voor het verwijderen van een teek.
JP5825757B2 (ja) * 2007-02-11 2015-12-02 マップ・ファーマシューティカルズ・インコーポレイテッド 副作用プロファイルを最小限にしながら片頭痛の迅速な緩和を可能にするｄｈｅの治療上の投与方法
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
CA151549S (en) 2013-02-14 2014-06-04 Clement Clarke Int Ltd Spacer for an asthma inhaler
US10207065B2 (en) 2013-07-12 2019-02-19 John H. Silva Mouthpiece for inhalers
USD748242S1 (en) * 2014-07-11 2016-01-26 H. Stuart Campbell Inhaler mouthpiece
KR20230116786A (ko) * 2020-12-01 2023-08-04 리버스피에이에이치 엘엘씨 만성 폐쇄성 폐질환, 천식, 폐렴, 기관지염, 낭포성 섬유증, 폐부종, 간질성 폐 질환, 사르코이드증, 특발성 폐섬유증, 급성 호흡곤란 증후군 및 폐동맥 고혈압을 치료하기 위한 방법 및 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555972A (xx) * 1956-03-21
US2890697A (en) * 1957-03-15 1959-06-16 Wilton E Van Sickle Enclosed medicament container and atomizer
US3012555A (en) * 1959-05-18 1961-12-12 Meshberg Philip Dispensing package for material under pressure
US3183907A (en) * 1962-06-25 1965-05-18 Merck & Co Inc Device for inhalation aerosol
JPS4214552Y1 (xx) * 1964-12-30 1967-08-18
JPS4514212Y1 (xx) * 1966-11-02 1970-06-16
US3559851A (en) * 1969-05-27 1971-02-02 Valve Corp Of America Fully-emptying valve assemblage
JPS566680Y2 (xx) * 1972-04-19 1981-02-13

Also Published As

Publication number Publication date
SE7405022L (xx) 1974-12-30
GB1471917A (en) 1977-04-27
YU36435B (en) 1984-02-29
CH577832A5 (xx) 1976-07-30
IE40616B1 (en) 1979-07-18
US3809294A (en) 1974-05-07
SE405448B (sv) 1978-12-11
DK152967C (da) 1988-10-24
ATA299974A (de) 1977-07-15
CA1043208A (en) 1978-11-28
DK343874A (xx) 1975-02-17
FR2234905B1 (xx) 1980-09-12
IL44401A (en) 1976-10-31
IL44401A0 (en) 1974-06-30
JPS5049886A (xx) 1975-05-02
DE2415360C2 (de) 1982-10-28
AU6676274A (en) 1975-09-18
AT342211B (de) 1978-03-28
FR2234905A1 (xx) 1975-01-24
AR198562A1 (es) 1974-06-28
NL7404626A (xx) 1974-12-31
DK152967B (da) 1988-06-06
NL178655C (nl) 1986-05-01
CS182257B2 (en) 1978-04-28
BE813512A (fr) 1974-10-09
DE2415360A1 (de) 1975-01-23
NL178655B (nl) 1985-12-02
YU98974A (en) 1982-02-25
SU537614A3 (ru) 1976-11-30
JPS6010737B2 (ja) 1985-03-19
ZA741633B (en) 1975-03-26
IT1003994B (it) 1976-06-10
PL89980B1 (xx) 1976-12-31
PH11643A (en) 1978-05-08
ES427755A1 (es) 1976-08-01
IE40616L (en) 1974-12-27
DD125188A5 (xx) 1977-04-06

Similar Documents

Publication Publication Date Title
CH620207A5 (xx)
DE2120495A1 (de) Neue Trialkoxychinazolin-Verbindungen und Verfahren zu ihrer Herstellung
DE2165962C2 (de) 4-Hydroxy-6-arylpyrimidine
DE2418344A1 (de) Derivate von 3-nitrocumarinen enthaltende arzneimittel, neue 3-nitrocumarine und verfahren zu ihrer herstellung
DE2625222C3 (de) 13-Dithiacyclopentan-2-ylidenmalonsäureester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2135543A1 (de) Benzthiazolderivate enthaltende arzneimittel
EP0091114B1 (de) Pharmazeutisch wirksame organische Germaniumverbindungen
DE2206385C2 (de) 2-Amino-4,5,7,8-tetrahydro-6H-oxazolo-[4,5-d]azepinderivate
DE2700073C2 (xx)
EP0095641B1 (de) Chinazolinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE3240112C2 (xx)
EP0061654B1 (de) Vincamin-cyclamat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
EP0324184B1 (de) 2-Amino-1,2,3,4-tetrahydroisochinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69328357T2 (de) Komplex von 2-aminoäthansulfonsäure und zink
DE1568552C3 (de) N-acylierte 1 -Chlorbenzol-24-disulfonamide und Verfahren zu ihrer Herstellung
DE69012213T2 (de) Phenylessigsäurederivat.
DE2164988C3 (de) 2,2-Diphenylcyclopropancarbonsäureesterderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3546319C2 (xx)
EP0324988A1 (de) 4-Chlor-3-sulfamoyl-benzoesäure-hydrazide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittelpräparate und Verwendung der neuen Verbindungen zur Herstellung von diuretischen und salzentziehend wirkenden Arzneimittelpräparaten
DE3245950A1 (de) Verfahren zur herstellung substituierter pyridine
DE1902694B2 (de) 2- (3-trifluormethylanilino) -nicotin-saeureamidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
AT304573B (de) Verfahren zur Herstellung von neuen Purin-Verbindungen und von deren Salzen
DE1942854A1 (de) Neue substituierte 3-Amino-4-halogensydnonimine
DE2757929A1 (de) Neue pyrido-eckige klammer auf 1,2-a eckige klammer zu -v-triazolo- eckige klammer auf 4,5-d eckige klammer zu pyrimidinone, deren salze und verfahren zu deren herstellung
DE2235400C3 (de) ^Chlor-S-sulfamoyl-anthranilsäuren, deren Salze, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased